GSK3685032
GSK3685032 is a potent, selective, and reversible non-covalent inhibitor of DNMT1 (IC50 = 36 nM) . It induces DNA demethylation and gene reactivation, demonstrating robust anti-proliferative effects in cancer cell lines and in vivo tumor models, making it a valuable tool for epigenetic and oncology research.
Product Specifications
CAS Number
2170137-61-6
Product Name Alternative
Cancer, DNA Methyltransferase, DNA MTases, DNAMethyltransferase, DNMT1, DNMTs, GSK3685032, GSK-3685032, GSK 3685032, leukemia, GDM-1, lymphoma, Inhibitor, inhibit, multiple myeloma, MV4–11
Field of Research
Epigenetics & Chromatin
Purity
98.56% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.76 mM) ; DMSO:26.4 mg/mL (62.78 mM)
Smiles
CCc1c (C#N) c (SC (C (N) =O) c2ccccc2) nc (N2CCC (N) CC2) c1C#N
Molecular Formula
C22H24N6OS
Molecular Weight
420.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2442708 1.0 µg DNA
TRAV4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
GTR15150080 1 Vial
Lentiviral mouse Ovgp1 shRNA (UAS) - Lentiviral mouseOvgp1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details MBS6474414-01 0.2 mL
EphB2, CT (Ephrin Type-B Receptor 2, Tyrosine-protein Kinase Receptor EPH-3, DRT, Receptor Protein-Tyrosine Kinase HEK5, ERK, EPH-like Kinase 5, EK5, Tyrosine-protein Kinase TYRO5, Renal Carcinoma Antigen NY-REN-47, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5) (A
Sign In for Pricing
View Details MBS6474414-02 5x 0.2 mL
EphB2, CT (Ephrin Type-B Receptor 2, Tyrosine-protein Kinase Receptor EPH-3, DRT, Receptor Protein-Tyrosine Kinase HEK5, ERK, EPH-like Kinase 5, EK5, Tyrosine-protein Kinase TYRO5, Renal Carcinoma Antigen NY-REN-47, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5) (A
Sign In for Pricing
View Details